Rainbow Children's Medicare Ltd
Financial Results approved in the Board Meeting held on May 23, 2026.
RESULTS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 27 May 2026, 03:43 PM IST · BSE ID: 6cb9f5b7-e8d0-49d7-b42d-8de3cd881f3b
View Original BSE Filing (PDF)
💡
In Simple Terms
The company released its full-year financial results and proposed a cash payout to shareholders, while also re-appointing key leaders.
🤖 AI Summary
- Board approved audited standalone and consolidated financial results for Q4 FY26 and FY26 ended March 31, 2026.
- A final dividend of ₹ 3.5/- per Equity Share (@ 35%) for FY26 was recommended, pending shareholder approval.
- The 28th Annual General Meeting (AGM) is scheduled for Wednesday, July 29, 2026, via VC/OVAM.
- July 21, 2026, fixed as the Record Date for the final dividend and 28th Annual General Meeting.
- Re-appointment of Dr. Ramesh Kancharla as Chairman & Managing Director for five years approved, subject to AGM.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Final Dividend per Equity Share
₹ 3.5/-
Final Dividend Percentage
35%
Face Value per Share
₹ 10/-
🏢 How This Affects the Company
The recommended final dividend of ₹ 3.5/- per Equity Share will result in a cash outflow for the company upon shareholder approval and disbursement.
The re-appointment of key management personnel like Dr. Ramesh Kancharla as Chairman and Managing Director provides leadership stability for the next five years.
👥 What This Means For Shareholders
✅
Action Required
Shareholders must approve the final dividend and director re-appointments at the 28th Annual General Meeting on July 29, 2026.
👤
Who Is Affected
Shareholders holding equity shares on July 21, 2026, the Record Date, will be eligible for the final dividend of ₹ 3.5/- per Equity Share, if approved.
🔍
Management Signal
Management intends to provide shareholder returns through dividends and maintain continuity in leadership by re-appointing key directors for new terms.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Shareholder approval of final dividend at 28th Annual General Meeting on July 29, 2026.
Dividend dispatch/credit to eligible shareholders within 30 days of AGM conclusion.
Shareholder approval for re-appointment of directors at the 28th Annual General Meeting.
LOW RISK
The filing indicates routine corporate governance activities and financial disclosures.
💡 Investor Takeaway
Rainbow Children's Medicare Ltd. approved its audited standalone and consolidated financial results for FY26 and recommended a final dividend of ₹ 3.5/- per Equity Share. Key management and independent directors were approved for re-appointment, pending shareholder approval at the July 29, 2026 AGM.
⚖️ Strengths & Concerns
✅ Positives
- Board recommended a final dividend of ₹ 3.5/- per Equity Share for FY26, indicating shareholder return consideration.
- Re-appointment of key management, including Dr. Ramesh Kancharla for five years, ensures leadership continuity.
📅 Company Track Record
Rainbow Children's Medicare Limited was incorporated in 1998, as noted by its CIN: L85110TG1998PLC029914, and the upcoming 28th Annual General Meeting suggests a long operational history. No previous filings were provided in the context for specific past financial performance or dividend history.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What is the final dividend recommended by Rainbow Children's Medicare Ltd. for FY26?
Rainbow Children's Medicare Ltd. recommended a final dividend of ₹ 3.5/- per Equity Share for the Financial Year ended March 31, 2026.
What is the Record Date for the final dividend for Rainbow Children's Medicare Ltd.?
The Record Date for the purpose of payment of Final Dividend for Financial Year 2025-26 is fixed as Tuesday, July 21, 2026.
When is Rainbow Children's Medicare Ltd.'s 28th Annual General Meeting?
The 28th Annual General Meeting of Rainbow Children's Medicare Ltd. is scheduled for Wednesday, July 29, 2026.
Who was re-appointed as Chairman and Managing Director of Rainbow Children's Medicare Ltd.?
Dr. Ramesh Kancharla (DIN: 00212270) was approved for re-appointment as the Chairman and Managing Director for five consecutive years, from August 11, 2026, till August 10, 2031.
What is the face value per share for Rainbow Children's Medicare Ltd.?
The face value per share for Rainbow Children's Medicare Ltd. is ₹ 10/- per share.
Questions based on this BSE filing only. For information purposes.